FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to resuscitation and intensive care, pulmonology, and is intended for the treatment of patients with pneumonia caused by a new coronavirus infection COVID-19. A method for treating patients with a new coronavirus infection COVID-19 with high-flow oxygenation includes inhaling nitric oxide into both nostrils of the patient during his spontaneous breathing from a distance of 8 cm with a nitric oxide concentration of 1100 ppm for 5 minutes 2-3 times a day, and alternate between the time of the treatment session according to the individual needs of inhalation of nitric oxide with high-flow oxygenation, while additionally the skin surface of the entire back of the patient in the prone position is treated with nitric oxide flows with a concentration of 1100 ppm from a distance of 8 cm for 5 minutes 2-3 times a day for 5-10 days before relief of signs of acute respiratory distress syndrome.
EFFECT: invention provides an effective and safe method for treating patients with pneumonia caused by COVID-19, of moderate and severe severity, with spontaneous breathing, who are on high-flow oxygenation, by improving respiratory function, increasing the level of blood saturation, and eliminating indications for intubation and resuscitators.
1 cl, 6 dwg, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING PATIENTS WITH NOVEL CORONAVIRUS INFECTION COVID-19 WITH SPONTANEOUS RESPIRATION | 2023 |
|
RU2824264C1 |
METHOD OF RESPIRATORY THERAPY IN NEW CORONAVIRUS INFECTION COVID-19 IN PATIENTS WITH RESPIRATORY FAILURE, WHO ARE ON SPONTANEOUS BREATHING | 2021 |
|
RU2769489C1 |
METHOD OF REHABILITATION, COMBINING HYPO- AND HYPERBARIC OXYGENATION, FOR PATIENTS SUFFERING NEW CORONAVIRUS INFECTION | 2023 |
|
RU2821549C1 |
METHOD FOR COVID-19 PNEUMONIA TREATMENT | 2020 |
|
RU2745535C1 |
METHOD FOR IMPROVING OXYGENATING PULMONARY FUNCTION IN THE PATIENTS WITH A NEW CORONAVIRAL INFECTION (COVID-19) WITH RESPIRATORY FAILURE WHO ARE ON RESPIRATORY SUPPORT | 2020 |
|
RU2735797C1 |
METHODS FOR TREATING INFECTIOUS DISEASES CAUSED BY CORONAVIRUS | 2021 |
|
RU2772701C1 |
METHOD FOR TREATING DYSOSMIA CAUSED BY CORONAVIRUS INFECTION | 2021 |
|
RU2791808C2 |
Respiratory therapy method for new coronavirus infection COVID-19 in patients on artificial lung ventilation | 2020 |
|
RU2744550C1 |
AGENT FOR REDUCING RISK AND RELIEVING SYMPTOMS OF BETA-CORONAVIRUS INFECTION | 2021 |
|
RU2747890C1 |
A METHOD FOR THE TREATMENT OF RESPIRATORY FAILURE (HYPOXEMIA) IN PATIENTS WHO HAVE HAD AN INFECTION WITH THE SARS-CoV-2 VIRUS | 2022 |
|
RU2784998C1 |
Authors
Dates
2022-12-29—Published
2022-05-13—Filed